Merit Medical Systems (MMSI) Stock Price
Merit Medical Systems Price
Revenue has compounded at 11.5% per year over the past 19 years to 1.51 B USD. Earnings per share have grown at 10.0% per year over the last 19 years. Merit Medical Systems's net margin stands at 8.5%, up from 4.5% several years earlier. Analysts set a median price target of 100.00 USD, implying 17.5% above the current price. Of 17 analysts, 14 rate the stock a buy — an overall Buy consensus.
Merit Medical Systems stock price
Merit Medical Systems business model & stock analysis
Frequently asked questions about Merit Medical Systems
Merit Medical Systems Inc is a medical device company that focuses on designing, manufacturing, and distributing medical products to improve patient outcomes. Their business model involves developing and providing innovative and high-quality medical devices and accessories to healthcare professionals worldwide. Merit Medical systems Inc aims to enhance patient care and clinical outcomes through their comprehensive portfolio of products, which includes catheters, inflation devices, guide wires, and many other medical devices. Their commitment to research, development, and continuous innovation has made them a trusted name in the medical industry.
Merit Medical Systems Inc is primarily active in the healthcare industry.
The main competitors of Merit Medical Systems Inc in the market include Becton Dickinson and Company, Boston Scientific Corporation, Medtronic PLC, and Smiths Medical.
Merit Medical Systems Inc is a reputable company in the medical device industry. Established in 1987, Merit Medical specializes in developing and manufacturing innovative and high-quality medical devices to enhance patient outcomes worldwide. With a focus on interventional and diagnostic procedures, the company offers a broad range of products including catheters, syringes, drainage systems, and more. Merit Medical has grown significantly since its inception, expanding its global presence through strategic acquisitions and partnerships. Its commitment to delivering superior healthcare solutions has earned Merit Medical a strong reputation among healthcare professionals and patients alike.
Merit Medical Systems Inc has achieved several significant milestones throughout its history. Since its inception, the company has strived to provide innovative and high-quality medical products to healthcare professionals and patients globally. One notable milestone is the development and commercialization of the unique Merit Laureate® hydrophilic guide wire, which offers enhanced trackability and navigation during medical procedures. Additionally, Merit Medical Systems Inc has successfully expanded its product portfolio, introducing a wide range of state-of-the-art devices for cardiovascular, endoscopy, and interventional radiology procedures. The company's commitment to research and development, coupled with its dedication to improving patient outcomes, has solidified Merit Medical Systems Inc as a trusted leader in the medical device industry.
Merit Medical Systems Inc is primarily present in various countries and regions across the globe. As a leading healthcare company, Merit Medical Systems Inc operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a widespread presence, the company serves healthcare professionals and patients alike in these regions. Merit Medical Systems Inc's commitment to expanding its presence across diverse markets underscores its dedication to providing innovative medical devices and solutions internationally.
Merit Medical Systems Inc represents values and a corporate philosophy centered around patient care, innovation, integrity, and collaboration. As a leading global manufacturer and distributor of medical devices and supplies, Merit Medical Systems Inc prioritizes improving patient outcomes through the development of cutting-edge medical solutions. With a commitment to ethical business practices, the company strives to maintain the trust of healthcare professionals and patients alike. Merit Medical Systems Inc fosters a culture of innovation, leveraging expertise and partnerships to deliver advanced medical technologies. By placing emphasis on collaboration and teamwork, the company strives to continuously improve patient care and positively impact the healthcare industry.
Analysts currently set an average price target of 99.22 USD for the Merit Medical Systems stock (median: 100.00 USD), implying +16.6 % versus the latest price. The consensus is based on 17 analyst ratings.
17 analysts currently rate the Merit Medical Systems stock: 14 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Merit Medical Systems to generate revenue of 1.64 B USD and earnings per share of 4.33 USD.
Converted at the current exchange rate, the Merit Medical Systems share trades at 75.98 EUR (85.09 USD).
The Merit Medical Systems share (MMSI) is listed on 3 stock exchanges, including: NASDAQ (MMSI), Frankfurt (MM3.F), München (MM3.MU).
Merit Medical Systems Inc. is a US-based company that specializes in the development, manufacturing, and distribution of products for the diagnosis, treatment, and management of patients with critical medical needs. The company was founded in 1987 and works closely with physicians and healthcare professionals to develop innovative products that enable improved clinical efficiency and patient outcomes. Merit Medical Systems focuses on various areas such as interventional radiology, cardiology, endoscopy, dialysis, oncology, and infusion. Each area has its own unique range of products tailored to the specific needs of patients and healthcare professionals. In the field of interventional radiology, Merit Medical Systems offers a wide range of products such as catheters, guide wires, and stents for diagnostic and therapeutic purposes. This includes products like Embosphere Microspheres embolization particles for the treatment of liver tumors and the AceWire guide wire system. In cardiology, Merit Medical focuses on providing solutions for complex cardiac procedures including the treatment of congenital heart defects, vascular narrowing, or valve problems. One example is the Prelude Sheath Introducer system for transcatheter aortic valve implantation (TAVI), a minimally invasive alternative to open heart surgery. In the field of endoscopy, Merit Medical Systems offers a wide range of products for diagnostic and therapeutic purposes for the gastrointestinal tract system, such as the Bull's Horn Suprapubic Catheter for percutaneous kidney stone removal. In the field of dialysis, Merit Medical Systems' portfolio includes products for hemodialysis, peritoneal dialysis, and hemofiltration. One example is the Hero Graft for dialysis patients, which allows for long-lasting and secure vascular access maintenance. In oncology, Merit Medical focuses on interventions for tumors, such as the STAR Tumor Ablation System for the treatment of malignant liver tumors, the eIFU NanoKnife for the treatment of soft tissue tumors like the pancreas or lung. Another important segment of Merit Medical Systems is infusion, which includes a wide range of products such as catheters, ports, and infusion pumps for medication and fluid delivery. The Spectrum Catheter and Port system are notable in this area. Merit Medical Systems has an extensive network of sales partners and branches throughout North America, Europe, the Middle East, and Asia to deliver products to customers quickly and effectively. The company's business model is based on providing innovative, high-quality products along with excellent customer service and training to create value for customers. Merit Medical Systems follows a strategy of continuously increasing market share to enhance revenue growth and profitability. In summary, Merit Medical Systems is an innovative company specializing in the development, manufacturing, and distribution of products for critical medical applications. With a wide range of areas and products, the company focuses on continuous innovation, high quality, and excellent customer service to increase its market share and competitiveness.
The expected revenue of Merit Medical Systems is 1.64 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Merit Medical Systems is 260.14 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Merit Medical Systems is currently 19.63. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Merit Medical Systems stock.
The price-to-sales ratio (P/S) of Merit Medical Systems is currently 3.12. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Merit Medical Systems stock.
The Eulerpool Quality Score for Merit Medical Systems is 5/10.
The ISIN of Merit Medical Systems is US5898891040. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Merit Medical Systems is 882361. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Merit Medical Systems is MMSI. The ticker symbol is used to trade Merit Medical Systems shares on the stock exchange.
Merit Medical Systems stock
Merit Medical Systems Peer Group
Merit Medical Systems Ticker
Merit Medical Systems FIGI
All fundamentals and in-depth analysis of Merit Medical Systems
Our stock analysis for Merit Medical Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merit Medical Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.